Healthcare
Live Price
Offline$1.09
+12.37% today
1Y Change
+147.73%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Talphera, Inc. (TLPH) is a Healthcare stock with a market cap of $20.00M and listed on NASDAQ. The stock last traded around $1.09 and up 147.7% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +32.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +32.0%, free cash flow +10.4% with operating margin -48157.1% and ROIC -52.0%. Valuation already assumes a fairly strong business story at price/sales 673.1. Stock Foundry combines TLPH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TLPH
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TLPH Max Drawdown
-50.68%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TLPH and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$378.0K
FY Net Income
-$35.1M
-182.6% YoY
Free Cash Flow
-$31.8M
-10.9% YoY
Revenue Growth
+0.0%
EPS Growth
+32.0%
Gross Margin
-4075.0%
Net Margin
-51035.7%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 28K | 0 | 651K | 0 | 378K |
| Gross Profit | 28K | -7M | -5M | -2M | -3M |
| Operating Income | -13M | -15M | -17M | -20M | -18M |
| EBITDA | -13M | -15M | -17M | 62M | -16M |
| Net Income | -14M | -13M | -18M | 43M | -35M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 6M | 9M | 6M | 15M | 8M |
| Total Assets | 30M | 18M | 20M | 47M | 78M |
| Total Liabilities | 13M | 10M | 6M | 26M | 114M |
| Shareholder Equity | 17M | 8M | 14M | 22M | -36M |
| Total Debt | 6M | 7M | 0 | 10M | 19M |
| Net Debt | 605K | -2M | -6M | -5M | 11M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
30M
-5.9% YoY
Capital Expenditures
2M
-401.9% YoY
Free Cash Flow
32M
-10.9% YoY
Key ratios
Gross Margin
-4075.0%
Operating Margin
-48157.1%
Net Margin
-51035.7%
ROE
-118.0%
Debt / Equity
0.38x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.